AtriCure, Inc.

ATRC Healthcare Medical Instruments & Supplies

AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024. In the quarter to June 2026, revenue grew 12.8%, EPS grew 238.5%, free cash flow fell 2.79% and total debt fell 4.43%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

56.09 1.69 −2.92%
Market cap
$2.9B
P/E
259×
Fwd P/E
591×
Dividend yield
—
F-score
7/9
Altman Z
7.31
Beneish M
−2.91
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 0.00 129.18
P/S ratio
3.26 3.53 2.50 2.39
P/FCF ratio
562.68 103.31 58.32 58.91
P/Operating CF
63.23 94.32 (345.09) 61.36
P/B ratio
3.54 3.84 2.80 2.64
Price to Tangible BV
8.82 9.03 6.53 5.71
EV/Sales
3.16 3.40 2.40 2.26
EV/EBITDA
0.00 157.03 72.75 37.60
EV/Operating CF
37.91 31.67 20.59 19.80
EV/FCF
544.89 99.30 56.05 55.62
Quick Ratio
2.71 2.87 2.97 3.02
Current Ratio
3.87 3.96 4.29 4.22
Net Debt/EBITDA
(13.49) (12.19) (12.60) (6.42)
Debt/Assets
11.60% 11.22% 11.15% 10.50%
Debt/Equity
0.15 0.15 0.15 0.14
Asset Turnover
0.83 0.85 0.89 0.89
Operating CF/Net income
(100.06) 11.40 (37.00) 2.48
Capex/Depreciation
(0.49) (0.31) (0.72) (0.70)
Interest Coverage
0.14 1.66 0.39 7.33
Research and Development Expense of Revenue
17.05% 17.44% 17.16% 17.19%
Selling, General and Administrative Expense of Revenue
58.27% 55.76% 59.86% 53.75%
Intangible Assets out of Total Assets
0.45 0.43 0.44 0.41
Share Based Compensation of Revenue
9.25% 8.01% 7.98% 8.02%
Graham Net Nets
0.08 0.08 0.12 0.14
Graham Number
0.00 0.00 0.00 7.19
Earnings Yield
(1.72%) (0.60%) (0.33%) 0.77%
Free Cash Flow Yield
0.18% 0.97% 1.71% 1.70%
Revenue per Share
2.80 2.94 2.92 3.16
Operating CF per Share
0.56 0.42 (0.08) 0.46
Capex per Share
(0.05) (0.03) (0.08) (0.08)
Free Cash Flow per Share
0.50 0.39 (0.16) 0.38
Cash per Share
3.09 3.51 3.02 3.45
Shareholders Equity per Share
9.94 10.30 10.17 10.61
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
9.94 10.30 10.17 10.61
Free Cash Flow
24.11 18.43 (7.85) 18.43
Working Capital
223.27 241.00 240.50 263.62
Capital Expenditures
(2.60) (1.60) (3.85) (3.77)
Net Current Asset Value
142.18 160.27 161.40 185.32
EV/EBIT
0.00 0.00 0.00 99.74
Capex to Sales
0.02 0.01 0.03 0.02
Price to Operating Income
0.00 0.00 0.00 105.64
Other line items
Average Receivables
58.94 63.50 67.32 72.99
Average Payables
28.60 25.17 27.87 30.76
Average Inventory
77.75 76.91 78.03 80.13
Average Assets
625.26 631.75 617.81 642.75
Average Common Equity
470.76 476.45 473.16 490.46

Fold the line items

Columns are period end dates